Pediatric Ritalin may affect young brains

Jul 18, 2007

U.S. medical researchers have discovered use of the attention deficit hyperactivity disorder drug Ritalin by young children might affect their brains.

The Weill Cornell Medical College animal study is among the first to investigate the effects of Ritalin (methylphenidate) on the neurochemistry of the developing brain.

Between 2 percent and 18 percent of U.S. children are thought to be affected by ADHD and Ritalin -- a stimulant similar to amphetamine and cocaine -- remains one of the most prescribed drugs for the behavioral disorder.

"The changes we saw in the brains of treated rats occurred in areas strongly linked to higher executive functioning, addiction and appetite, social relationships and stress, said Professor Teresa Milner, the study's lead author. "These alterations gradually disappeared over time once the rats no longer received the drug."

The scientists said their findings suggest physicians should be careful in their diagnosis of ADHD before prescribing Ritalin. That's because Ritalin might be helpful in battling the disorder but harmful if given to youngsters with healthy brain chemistry.

The research appears in the Journal of Neuroscience.

Copyright 2007 by United Press International

Explore further: FDA approves AbbVie combo hepatitis C treatment

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.